138.98
price up icon1.16%   0.68
 
loading
Genedx Holdings Corp stock is traded at $138.98, with a volume of 223.63K. It is up +1.16% in the last 24 hours and up +18.30% over the past month. GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$138.30
Open:
$134.91
24h Volume:
223.63K
Relative Volume:
0.38
Market Cap:
$4.00B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-44.69
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+1.77%
1M Performance:
+18.30%
6M Performance:
+108.09%
1Y Performance:
+86.14%
1-Day Range:
Value
$134.00
$140.82
1-Week Range:
Value
$128.75
$144.79
52-Week Range:
Value
$55.17
$146.00

Genedx Holdings Corp Stock (WGS) Company Profile

Name
Name
Genedx Holdings Corp
Name
Phone
888-729-1206
Name
Address
333 LUDLOW STREET, STAMFORD
Name
Employee
1,000
Name
Twitter
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
WGS's Discussions on Twitter

Compare WGS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
WGS
Genedx Holdings Corp
139.24 4.00B 267.23M -83.50M -59.99M -3.11
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
564.46 212.23B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
213.61 151.20B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
718.71 57.84B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
146.65 41.02B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
211.91 36.42B 15.90B 1.28B 2.21B 7.2842

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-25 Initiated Canaccord Genuity Buy
Jul-09-25 Initiated Piper Sandler Overweight
May-15-25 Initiated Guggenheim Buy
May-09-25 Upgrade Jefferies Hold → Buy
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-10-24 Initiated Craig Hallum Buy
Jun-03-24 Resumed Jefferies Hold
View All

Genedx Holdings Corp Stock (WGS) Latest News

pulisher
08:00 AM

GeneDx to Participate in Upcoming Investor Conferences - Business Wire

08:00 AM
pulisher
07:34 AM

Corton Capital Inc. Invests $339,000 in GeneDx Holdings Corp. $WGS - MarketBeat

07:34 AM
pulisher
07:11 AM

Key metrics from GeneDx Holdings Corp. Equity Warrant’s quarterly dataEarnings Beat & Low Drawdown Investment Strategies - newser.com

07:11 AM
pulisher
07:01 AM

Can GeneDx Holdings Corp. stock deliver surprise earnings beatJobs Report & Growth Focused Investment Plans - newser.com

07:01 AM
pulisher
06:30 AM

Real time pattern detection on GeneDx Holdings Corp. Equity Warrant stockFed Meeting & Daily Chart Pattern Signal Reports - newser.com

06:30 AM
pulisher
06:28 AM

GeneDx Holdings Corp. $WGS Shares Sold by Hussman Strategic Advisors Inc. - MarketBeat

06:28 AM
pulisher
06:09 AM

What moving averages say about GeneDx Holdings Corp. Equity WarrantJuly 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com

06:09 AM
pulisher
05:11 AM

Price action breakdown for GeneDx Holdings Corp. Equity Warrant2025 Institutional Moves & Consistent Growth Stock Picks - newser.com

05:11 AM
pulisher
03:39 AM

Volume spikes in GeneDx Holdings Corp. stock – what they mean2025 Trade Ideas & High Win Rate Trade Tips - newser.com

03:39 AM
pulisher
01:16 AM

Visual trend scoring systems applied to GeneDx Holdings Corp. Equity WarrantMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com

01:16 AM
pulisher
Nov 03, 2025

How rising interest rates impact GeneDx Holdings Corp. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will GeneDx Holdings Corp. Equity Warrant stock outperform international peersWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why GeneDx Holdings Corp. stock could be next big winnerForecast Cut & Technical Pattern Recognition Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will GeneDx Holdings Corp. Equity Warrant stock continue dividend increasesJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How high can GeneDx Holdings Corp. stock go2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

GeneDx Holdings Corp. stock prediction for this weekGlobal Markets & High Return Stock Watch Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will GeneDx Holdings Corp. stock maintain growth storyTrade Signal Summary & Technical Pattern Alert System - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Heatmap analysis for GeneDx Holdings Corp. and competitorsMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Zweig DiMenna Associates LLC Buys 129,000 Shares of GeneDx Holdings Corp. $WGS - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Should you hold or exit GeneDx Holdings Corp. Equity Warrant nowJuly 2025 Volume & Technical Entry and Exit Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Kovack Advisors Inc. Makes New Investment in GeneDx Holdings Corp. $WGS - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Can momentum traders help lift GeneDx Holdings Corp. Equity Warrant2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is GeneDx Holdings Corp. stock a top pick in earnings seasonJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Oppenheimer Asset Management Inc. Invests $236,000 in GeneDx Holdings Corp. $WGS - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Will GeneDx Holdings Corp. stock split again soonJuly 2025 Intraday Action & Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How GeneDx Holdings Corp. Equity Warrant stock performs in rising dollar environment - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can momentum traders help lift GeneDx Holdings Corp.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

GeneDx Holdings (WGS) Is Up 6.2% After Raised Guidance and FDA Breakthrough Designation – What's Changed - simplywall.st

Nov 02, 2025
pulisher
Nov 02, 2025

Can GeneDx Holdings Corp. stock resist market sell offsWeekly Market Summary & Safe Capital Allocation Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will GeneDx Holdings Corp. stock outperform tech sector in 2025Quarterly Risk Review & Weekly Stock Breakout Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Wall Street Zen Downgrades GeneDx (NASDAQ:WGS) to Hold - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

GeneDx (NASDAQ:WGS) CFO Sells $52,977.52 in Stock - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 2,158 Shares - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Is GeneDx Holdings Corp Equity Warrant a good long term investmentEarnings Forecast Updates & Outstanding Return Stocks - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Price action breakdown for GeneDx Holdings Corp.Weekly Trend Report & Fast Entry High Yield Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Jennison Associates LLC Has $36.73 Million Holdings in GeneDx Holdings Corp. $WGS - MarketBeat

Nov 01, 2025

Genedx Holdings Corp Stock (WGS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Genedx Holdings Corp Stock (WGS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Oct 29 '25
Sale
136.54
2,158
294,654
3,436
Feeley Kevin
CHIEF FINANCIAL OFFICER
Oct 29 '25
Option Exercise
0.00
753
0
4,145
Feeley Kevin
CHIEF FINANCIAL OFFICER
Oct 29 '25
Sale
136.54
388
52,978
3,757
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Sep 30 '25
Sale
108.17
12,858
1,390,911
1,720
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 30 '25
Option Exercise
32.67
1,246
40,707
10,001
Feeley Kevin
CHIEF FINANCIAL OFFICER
Sep 30 '25
Sale
108.38
6,609
716,261
3,392
diagnostics_research DGX
$177.71
price down icon 0.88%
diagnostics_research LH
$252.59
price down icon 2.04%
diagnostics_research WAT
$366.53
price up icon 6.09%
$201.07
price up icon 1.33%
diagnostics_research MTD
$1,414.07
price up icon 0.61%
diagnostics_research IQV
$211.86
price down icon 0.96%
Cap:     |  Volume (24h):